Henning Walczak

Henning Walczak is the Alexander von Humboldt Professor of Biochemistry at the University of Cologne, Germany, and also holds a part-time position as Professor of Cancer Biology at University College London (UCL), United Kingdom. Professor Walczak previously conducted research at the German Cancer Research Center in Heidelberg and at the biotech company Immunex Corp. in Seattle, WA, USA.Together with Peter Krammer, he founded the biotech firm Apogenix AG in Heidelberg. In 2007, Walczak transferred to London, initially as a Professor of Tumour Immunology at Imperial College before joining the UCL Cancer Institute in 2013.He has received numerous awards, including an ERC Advanced Grant and two Wellcome Trust Investigator Awards. In 2019, he was awarded an Alexander von Humboldt Professorship Award, one of the most prestigious research prizes in Germany, for his position as Professor and Chair of Biochemistry at the University of Cologne.